Mike HoneyHere's the latest variant picture for New South Wales, Australia.
The EG.5.* "Eris" variant (40%) has become dominant. XBB.2.3.* "Acrux" (23%) is also rising.
#COVID19 #Australia #NSW #Sydney #EG_5 #Eris #XBB_2_3 #Acrux @auscovid19
π§΅
Here's the latest variant picture for New South Wales, Australia.
"Deltacron" XBC.* (23%) is rising sharply to challenge the dominance of XBB.1.16.* "Arcturus" (29%).
XBB.2.3.* "Acrux" (15%) is also rising quite rapidly.
The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to June 19.
#COVID19 #Australia #NSW #Sydney #XBC #Deltacron #XBB_2_3 #Acrux #XBB_1_16 #Arcturus @auscovid19
π§΅
Here's the latest variant picture for Kenya.
XBB.1.22.* "Bellatrix" (48%) clan has been dominant recently, led by the FY.4 sub-lineage.
There was a rise in XBB.2.3.* "Acrux" (41%) clan in late May, led by the GE.1 sub-lineage.
The sample volumes are a bit sparse and patchy.
#COVID19 #Kenya #XBB_1_22 #Bellatrix #XBB_2_3 #Acrux
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
Here's the latest variant picture for Singapore.
XBB.2.3.* "Acrux" (33%) and XBB.1.16.* "Arcturus" (30%) are battling for dominance.
XBB.1.9.* "Hyperion" (23%) has rebounded during May.
Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.
The vigorous mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to May 23.
#COVID19 #Singapore #XBB_1_16 #Arcturus #XBB_2_3 #Acrux
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
Here's the latest variant picture for Malaysia.
XBB.1.16.* "Arcturus" (39%) now looks dominant over XBB.1.9.* "Hyperion" (22%).
XBB.2.3.* "Acrux" (11%) is rising, and might be the next to challenge.
Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.
The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to May 18, but look a bit patchy.
#COVID19 #Malaysia #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBB_2_3 #Acrux
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
Here's the latest variant picture for Vietnam.
XBB.1.16.* "Arcturus" (60%) has remained dominant.
XBB.1.9.* "Hyperion" (26%) looks like challenging next.
XBB.2.3.* "Acrux" (13%) is also rising.
Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.
The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volume has declined, and the available data is only up to May 7.
#COVID19 #Vietnam #XBB_1_16 #Arcturus #XBB_1_5 #Kraken #XBB_2_3 #Acrux
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
Here's the latest variant picture for New Zealand. The sample volumes seem representative up to May 18.
XBB.1.16.* "Arcturus" (28%) has been growing steadily and now appears dominant, displacing CH.1.1.* "Orthrus" (23%).
Be alert for conjunctivitis symptoms, which seem more common with the "Arcturus" variant, although it's wave has likely peaked already by now.
XBB.1.5.* "Kraken" (19%) and XBB.1.9.* "Hyperion" (15%) are both significant.
XBB.2.3.* "Acrux" (9%) is starting to rise
The vigorous mix of variants implies increased immediate reinfection risks, for those relying on immunity from a prior infection.
#COVID19 #NZ #XBB_1_16 #Arcturus #CH_1_1 #Orthrus #XBB_2_3 #Acrux
π§΅
Here's the latest variant picture for China.
XBB.1.9.* "Hyperion" (45%) is still dominant dominant.
XBB.1.16.* "Arcturus" (25%) looks like challenging next.
New clans XBB.1.22.* "Bellatrix" (9%) and XBB.2.3.* "Acrux" (8%) are beginning to rise.
The vigorous mix of very different variants raises the re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to May 10.
#COVID19 #China #XBB_1_9 #Hyperion #XBB_1_16 #Arcturus #XBB_1_22 #Bellatrix #XBB_2_3 #Acrux
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
Here's the latest variant picture for Singapore.
XBB.1.16.* "Arcturus" (39%) appears to have surged to dominance displacing XBB.2.3.* "Acrux" (25%).
Be alert for conjunctivitis symptoms, particularly associated with Arcturus variant.
The vigorous mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to May 9.
#COVID19 #Singapore #XBB_1_16 #Arcturus #XBB_2_3 #Acrux
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
Here's the latest variant picture for the XBB.2.3.* "Acrux" variant clan.
First, an animated map showing the spread of the XBB.2.3.* "Acrux" variant around the world. The earliest samples were found in mid-December in both Karnataka India and Delaware USA, so the origin is somewhat unclear. Singapore became another significant hub.
Locations are approximate - typically country and state/province.
Here's a link to the video file - feel free to share anywhere:
https://github.com/Mike-Honey/covid-19-genomes/raw/main/covid-19-genomes-map-XBB-2-3-Acrux.mp4